8-KRegulation FD

THERMO FISHER SCIENTIFIC INC. 8-K Report, Regulation FD Disclosure (Sep 17, 2021)

Filed September 17, 2021For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) hosted a virtual Investor Meeting on September 16, 2021, to discuss future performance expectations. The company provided guidance for 2022, projecting revenue of $40.3 billion and adjusted Earnings Per Share (EPS) of $21.16. Management emphasized that these are estimates and actual results may vary due to ongoing market uncertainties. The filing also clarified Thermo Fisher's use of non-GAAP financial measures, specifically adjusted EPS. This measure excludes certain costs such as acquisition-related expenses, restructuring charges, and amortization of intangible assets, which management believes provides a clearer view of the company's core operating performance and future prospects. Investors should note that GAAP measures are not provided on a forward-looking basis due to the unpredictability of certain exclusion items.

Key Highlights

  • 1Thermo Fisher provided 2022 revenue guidance of $40.3 billion.
  • 2The company anticipates 2022 adjusted EPS to be $21.16.
  • 3Forward-looking estimates are subject to market uncertainties and actual results may differ.
  • 4Investor Meeting included presentations on future performance expectations by senior management.
  • 5The company reiterated its use of non-GAAP financial measures, particularly adjusted EPS, to illustrate core operating performance.
  • 6Adjusted EPS excludes acquisition-related costs, restructuring charges, and amortization of intangibles.

Frequently Asked Questions

Thermo Fisher Scientific projects 2022 revenue of $40.3 billion and adjusted EPS of $21.16. It's important for investors to note these are estimates and subject to market uncertainties.

Thermo Fisher uses adjusted EPS to provide a clearer understanding of its core operating performance. It excludes items like acquisition-related costs, restructuring charges, amortization of acquisition-related intangible assets, and other infrequent or unpredictable gains/losses.

The materials presented at the virtual Investor Meeting can be found on Thermo Fisher's website at www.thermofisher.com by navigating to the 'Investors' section.

Risks include the duration and severity of the COVID-19 pandemic, technological changes, economic conditions, customer capital spending, government funding, international operations, intellectual property, regulatory changes, government contract regulations, and the successful integration of acquisitions like PPD, Inc.